Global Biomedical Nanotechnology Market

Biomedical Nanotechnology Comprehensive Study by Application (Diagnostics, Sensing, Drugs, Prostheses and Implants, Others), Product (Treatment, Nanomedicine (Nanosensors), Agricultural Technology, Genetic Engineering), End User (Hospital and Clinics, Research Institution, Agriculture, Others) Players and Region - Global Market Outlook to 2028

Biomedical Nanotechnology Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Biomedical Nanotechnology
Nanotechnology is the technology used to see and control atoms and molecules, biomedical nanotechnology is used in medical sciences for the therapeutic and diagnostic approaches for healthcare and medicine. The technology helps to detect and monitor diseases and is also applied in drugs, diagnostics, and implants. Biomedical nanotechnology is the new prospect of developing the scalable detection method, it is currently being used to mitigate COVID-19. Nanosensors show great ability to detect bacteria and viruses at very low concentrations and warn clinicians even before symptoms have shown or on patients with very low viral loads.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


"The NWA seeks to expand and strengthen connections between stakeholders in the nanotechnology sector as these relationships are the key to fulfilling the potentials of these various technologies. This will be achieved by engaging more industry members and facilitating industry-oriented programs, with an emphasis on supporting nanomanufacturing R&D projects with other educational research bodies. The NWA efforts will include the private or public spheres and active support and vigorous participation from both governments and companies is expected." Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Biomedical Nanotechnology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Altairnano (United States), Park Systems Corp (South Korea), HORIBA, Ltd. (Japan), Abionic SA (Switzerland), Catalytic Materials (United States), Advanced Nano Products Co. Ltd (South Korea), Chemat Technology Inc. (United States), eSpin Technologies (United States), ELITech Group (France) and GeneFluidics Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Hanwha Nanotech Corporation (South Korea), Hyperion Catalysis International (United States) and Integran Technologie Inc. (Canada).

Segmentation Overview
AMA Research has segmented the market of Global Biomedical Nanotechnology market by , Application (Diagnostics, Sensing, Drugs, Prostheses and Implants and Others) and Region.



On the basis of geography, the market of Biomedical Nanotechnology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Product, the sub-segment i.e. Treatment will boost the Biomedical Nanotechnology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital and Clinics will boost the Biomedical Nanotechnology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Introduction of Artificial Intelligence in Biomedical Nanotechnology and Continuous Research and Development in Biomedical Technology

Market Growth Drivers:
Increasing Need for Early Detecting, Monitoring and Preventing any Diseases in People and Need for Cancer Drug Delivery

Challenges:
Possibility of Adverse Health Effects and Environmental Risks of the Technology

Restraints:
High-Cost Investment Involve in Biomedical Nanotechnology and Stringent regulatory Compliance with Biomedical Nanotechnology

Opportunities:
Emerging Use of Biomedical Nanotechnology Solutions to Mitigate COVID-19 and Rising Demand for Biomedical Nanotechnology in Pharmaceutical Industries


"The evidence suggests that at present regulatory frameworks at the EU and UK level are sufficiently broad and flexible to handle nanotechnologies at their current stage of development. However, some regulations will need to be modified on a precautionary basis to reflect the fact that the toxicity of chemicals in the form of free nanoparticles and nanotubes cannot be predicted from their toxicity in a larger form and that in some cases they will be more toxic than the same mass of the same chemical in larger form. Future applications of nanotechnologies may have an impact on other areas of regulation as, for example, developments in sensor technology may have implications for legislation relating to privacy. It is therefore important that regulatory bodies include future applications of nanotechnologies in their horizon-scanning programs to ensure that any regulatory gaps are identified at an appropriate stage."

Key Target Audience
Biomedical Nanotechnology Manufactures, International Traders, Distributors and Suppliers of Biomedical Nanotechnology, Research and Development Institutes, Financial Institutes and Venture Capital, Hospitals and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Diagnostics
  • Sensing
  • Drugs
  • Prostheses and Implants
  • Others
By Product
  • Treatment
  • Nanomedicine (Nanosensors)
  • Agricultural Technology
  • Genetic Engineering

By End User
  • Hospital and Clinics
  • Research Institution
  • Agriculture
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Need for Early Detecting, Monitoring and Preventing any Diseases in People
      • 3.2.2. Need for Cancer Drug Delivery
    • 3.3. Market Challenges
      • 3.3.1. Possibility of Adverse Health Effects and Environmental Risks of the Technology
    • 3.4. Market Trends
      • 3.4.1. Introduction of Artificial Intelligence in Biomedical Nanotechnology
      • 3.4.2. Continuous Research and Development in Biomedical Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biomedical Nanotechnology, by Application, Product, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Biomedical Nanotechnology (Value)
      • 5.2.1. Global Biomedical Nanotechnology by: Application (Value)
        • 5.2.1.1. Diagnostics
        • 5.2.1.2. Sensing
        • 5.2.1.3. Drugs
        • 5.2.1.4. Prostheses and Implants
        • 5.2.1.5. Others
      • 5.2.2. Global Biomedical Nanotechnology by: Product (Value)
        • 5.2.2.1. Treatment
        • 5.2.2.2. Nanomedicine (Nanosensors)
        • 5.2.2.3. Agricultural Technology
        • 5.2.2.4. Genetic Engineering
      • 5.2.3. Global Biomedical Nanotechnology by: End User (Value)
        • 5.2.3.1. Hospital and Clinics
        • 5.2.3.2. Research Institution
        • 5.2.3.3. Agriculture
        • 5.2.3.4. Others
      • 5.2.4. Global Biomedical Nanotechnology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biomedical Nanotechnology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Altairnano (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Park Systems Corp (South Korea)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. HORIBA, Ltd. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abionic SA (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Catalytic Materials (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Advanced Nano Products Co. Ltd (South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Chemat Technology Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ESpin Technologies (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ELITech Group (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GeneFluidics Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biomedical Nanotechnology Sale, by Application, Product, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Biomedical Nanotechnology (Value)
      • 7.2.1. Global Biomedical Nanotechnology by: Application (Value)
        • 7.2.1.1. Diagnostics
        • 7.2.1.2. Sensing
        • 7.2.1.3. Drugs
        • 7.2.1.4. Prostheses and Implants
        • 7.2.1.5. Others
      • 7.2.2. Global Biomedical Nanotechnology by: Product (Value)
        • 7.2.2.1. Treatment
        • 7.2.2.2. Nanomedicine (Nanosensors)
        • 7.2.2.3. Agricultural Technology
        • 7.2.2.4. Genetic Engineering
      • 7.2.3. Global Biomedical Nanotechnology by: End User (Value)
        • 7.2.3.1. Hospital and Clinics
        • 7.2.3.2. Research Institution
        • 7.2.3.3. Agriculture
        • 7.2.3.4. Others
      • 7.2.4. Global Biomedical Nanotechnology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biomedical Nanotechnology: by Application(USD Million)
  • Table 2. Biomedical Nanotechnology Diagnostics , by Region USD Million (2017-2022)
  • Table 3. Biomedical Nanotechnology Sensing , by Region USD Million (2017-2022)
  • Table 4. Biomedical Nanotechnology Drugs , by Region USD Million (2017-2022)
  • Table 5. Biomedical Nanotechnology Prostheses and Implants , by Region USD Million (2017-2022)
  • Table 6. Biomedical Nanotechnology Others , by Region USD Million (2017-2022)
  • Table 7. Biomedical Nanotechnology: by Product(USD Million)
  • Table 8. Biomedical Nanotechnology Treatment , by Region USD Million (2017-2022)
  • Table 9. Biomedical Nanotechnology Nanomedicine (Nanosensors) , by Region USD Million (2017-2022)
  • Table 10. Biomedical Nanotechnology Agricultural Technology , by Region USD Million (2017-2022)
  • Table 11. Biomedical Nanotechnology Genetic Engineering , by Region USD Million (2017-2022)
  • Table 12. Biomedical Nanotechnology: by End User(USD Million)
  • Table 13. Biomedical Nanotechnology Hospital and Clinics , by Region USD Million (2017-2022)
  • Table 14. Biomedical Nanotechnology Research Institution , by Region USD Million (2017-2022)
  • Table 15. Biomedical Nanotechnology Agriculture , by Region USD Million (2017-2022)
  • Table 16. Biomedical Nanotechnology Others , by Region USD Million (2017-2022)
  • Table 17. South America Biomedical Nanotechnology, by Country USD Million (2017-2022)
  • Table 18. South America Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 19. South America Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 20. South America Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 21. Brazil Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 22. Brazil Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 23. Brazil Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 24. Argentina Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 25. Argentina Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 26. Argentina Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 27. Rest of South America Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 28. Rest of South America Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 29. Rest of South America Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 30. Asia Pacific Biomedical Nanotechnology, by Country USD Million (2017-2022)
  • Table 31. Asia Pacific Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 32. Asia Pacific Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 33. Asia Pacific Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 34. China Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 35. China Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 36. China Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 37. Japan Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 38. Japan Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 39. Japan Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 40. India Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 41. India Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 42. India Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 43. South Korea Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 44. South Korea Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 45. South Korea Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 46. Taiwan Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 47. Taiwan Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 48. Taiwan Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 49. Australia Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 50. Australia Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 51. Australia Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 55. Europe Biomedical Nanotechnology, by Country USD Million (2017-2022)
  • Table 56. Europe Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 57. Europe Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 58. Europe Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 59. Germany Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 60. Germany Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 61. Germany Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 62. France Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 63. France Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 64. France Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 65. Italy Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 66. Italy Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 67. Italy Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 68. United Kingdom Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 69. United Kingdom Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 70. United Kingdom Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 71. Netherlands Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 72. Netherlands Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 73. Netherlands Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 74. Rest of Europe Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 75. Rest of Europe Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 76. Rest of Europe Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 77. MEA Biomedical Nanotechnology, by Country USD Million (2017-2022)
  • Table 78. MEA Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 79. MEA Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 80. MEA Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 81. Middle East Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 82. Middle East Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 83. Middle East Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 84. Africa Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 85. Africa Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 86. Africa Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 87. North America Biomedical Nanotechnology, by Country USD Million (2017-2022)
  • Table 88. North America Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 89. North America Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 90. North America Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 91. United States Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 92. United States Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 93. United States Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 94. Canada Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 95. Canada Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 96. Canada Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 97. Mexico Biomedical Nanotechnology, by Application USD Million (2017-2022)
  • Table 98. Mexico Biomedical Nanotechnology, by Product USD Million (2017-2022)
  • Table 99. Mexico Biomedical Nanotechnology, by End User USD Million (2017-2022)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Biomedical Nanotechnology: by Application(USD Million)
  • Table 111. Biomedical Nanotechnology Diagnostics , by Region USD Million (2023-2028)
  • Table 112. Biomedical Nanotechnology Sensing , by Region USD Million (2023-2028)
  • Table 113. Biomedical Nanotechnology Drugs , by Region USD Million (2023-2028)
  • Table 114. Biomedical Nanotechnology Prostheses and Implants , by Region USD Million (2023-2028)
  • Table 115. Biomedical Nanotechnology Others , by Region USD Million (2023-2028)
  • Table 116. Biomedical Nanotechnology: by Product(USD Million)
  • Table 117. Biomedical Nanotechnology Treatment , by Region USD Million (2023-2028)
  • Table 118. Biomedical Nanotechnology Nanomedicine (Nanosensors) , by Region USD Million (2023-2028)
  • Table 119. Biomedical Nanotechnology Agricultural Technology , by Region USD Million (2023-2028)
  • Table 120. Biomedical Nanotechnology Genetic Engineering , by Region USD Million (2023-2028)
  • Table 121. Biomedical Nanotechnology: by End User(USD Million)
  • Table 122. Biomedical Nanotechnology Hospital and Clinics , by Region USD Million (2023-2028)
  • Table 123. Biomedical Nanotechnology Research Institution , by Region USD Million (2023-2028)
  • Table 124. Biomedical Nanotechnology Agriculture , by Region USD Million (2023-2028)
  • Table 125. Biomedical Nanotechnology Others , by Region USD Million (2023-2028)
  • Table 126. South America Biomedical Nanotechnology, by Country USD Million (2023-2028)
  • Table 127. South America Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 128. South America Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 129. South America Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 130. Brazil Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 131. Brazil Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 132. Brazil Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 133. Argentina Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 134. Argentina Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 135. Argentina Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 136. Rest of South America Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 137. Rest of South America Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 138. Rest of South America Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 139. Asia Pacific Biomedical Nanotechnology, by Country USD Million (2023-2028)
  • Table 140. Asia Pacific Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 141. Asia Pacific Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 142. Asia Pacific Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 143. China Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 144. China Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 145. China Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 146. Japan Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 147. Japan Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 148. Japan Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 149. India Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 150. India Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 151. India Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 152. South Korea Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 153. South Korea Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 154. South Korea Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 155. Taiwan Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 156. Taiwan Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 157. Taiwan Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 158. Australia Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 159. Australia Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 160. Australia Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 162. Rest of Asia-Pacific Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 163. Rest of Asia-Pacific Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 164. Europe Biomedical Nanotechnology, by Country USD Million (2023-2028)
  • Table 165. Europe Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 166. Europe Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 167. Europe Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 168. Germany Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 169. Germany Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 170. Germany Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 171. France Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 172. France Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 173. France Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 174. Italy Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 175. Italy Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 176. Italy Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 177. United Kingdom Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 178. United Kingdom Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 179. United Kingdom Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 180. Netherlands Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 181. Netherlands Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 182. Netherlands Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 183. Rest of Europe Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 184. Rest of Europe Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 185. Rest of Europe Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 186. MEA Biomedical Nanotechnology, by Country USD Million (2023-2028)
  • Table 187. MEA Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 188. MEA Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 189. MEA Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 190. Middle East Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 191. Middle East Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 192. Middle East Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 193. Africa Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 194. Africa Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 195. Africa Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 196. North America Biomedical Nanotechnology, by Country USD Million (2023-2028)
  • Table 197. North America Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 198. North America Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 199. North America Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 200. United States Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 201. United States Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 202. United States Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 203. Canada Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 204. Canada Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 205. Canada Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 206. Mexico Biomedical Nanotechnology, by Application USD Million (2023-2028)
  • Table 207. Mexico Biomedical Nanotechnology, by Product USD Million (2023-2028)
  • Table 208. Mexico Biomedical Nanotechnology, by End User USD Million (2023-2028)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biomedical Nanotechnology: by Application USD Million (2017-2022)
  • Figure 5. Global Biomedical Nanotechnology: by Product USD Million (2017-2022)
  • Figure 6. Global Biomedical Nanotechnology: by End User USD Million (2017-2022)
  • Figure 7. South America Biomedical Nanotechnology Share (%), by Country
  • Figure 8. Asia Pacific Biomedical Nanotechnology Share (%), by Country
  • Figure 9. Europe Biomedical Nanotechnology Share (%), by Country
  • Figure 10. MEA Biomedical Nanotechnology Share (%), by Country
  • Figure 11. North America Biomedical Nanotechnology Share (%), by Country
  • Figure 12. Global Biomedical Nanotechnology share by Players 2022 (%)
  • Figure 13. Global Biomedical Nanotechnology share by Players (Top 3) 2022(%)
  • Figure 14. Global Biomedical Nanotechnology share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Altairnano (United States) Revenue, Net Income and Gross profit
  • Figure 17. Altairnano (United States) Revenue: by Geography 2022
  • Figure 18. Park Systems Corp (South Korea) Revenue, Net Income and Gross profit
  • Figure 19. Park Systems Corp (South Korea) Revenue: by Geography 2022
  • Figure 20. HORIBA, Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 21. HORIBA, Ltd. (Japan) Revenue: by Geography 2022
  • Figure 22. Abionic SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Abionic SA (Switzerland) Revenue: by Geography 2022
  • Figure 24. Catalytic Materials (United States) Revenue, Net Income and Gross profit
  • Figure 25. Catalytic Materials (United States) Revenue: by Geography 2022
  • Figure 26. Advanced Nano Products Co. Ltd (South Korea) Revenue, Net Income and Gross profit
  • Figure 27. Advanced Nano Products Co. Ltd (South Korea) Revenue: by Geography 2022
  • Figure 28. Chemat Technology Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Chemat Technology Inc. (United States) Revenue: by Geography 2022
  • Figure 30. ESpin Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 31. ESpin Technologies (United States) Revenue: by Geography 2022
  • Figure 32. ELITech Group (France) Revenue, Net Income and Gross profit
  • Figure 33. ELITech Group (France) Revenue: by Geography 2022
  • Figure 34. GeneFluidics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. GeneFluidics Inc. (United States) Revenue: by Geography 2022
  • Figure 36. Global Biomedical Nanotechnology: by Application USD Million (2023-2028)
  • Figure 37. Global Biomedical Nanotechnology: by Product USD Million (2023-2028)
  • Figure 38. Global Biomedical Nanotechnology: by End User USD Million (2023-2028)
  • Figure 39. South America Biomedical Nanotechnology Share (%), by Country
  • Figure 40. Asia Pacific Biomedical Nanotechnology Share (%), by Country
  • Figure 41. Europe Biomedical Nanotechnology Share (%), by Country
  • Figure 42. MEA Biomedical Nanotechnology Share (%), by Country
  • Figure 43. North America Biomedical Nanotechnology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Altairnano (United States)
  • Park Systems Corp (South Korea)
  • HORIBA, Ltd. (Japan)
  • Abionic SA (Switzerland)
  • Catalytic Materials (United States)
  • Advanced Nano Products Co. Ltd (South Korea)
  • Chemat Technology Inc. (United States)
  • eSpin Technologies (United States)
  • ELITech Group (France)
  • GeneFluidics Inc. (United States)
Additional players considered in the study are as follows:
Hanwha Nanotech Corporation (South Korea) , Hyperion Catalysis International (United States) , Integran Technologie Inc. (Canada)
Select User Access Type

Key Highlights of Report


May 2023 219 Pages 67 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biomedical Nanotechnology Market Quantitative research analysis
Global Biomedical Nanotechnology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Altairnano (United States), Park Systems Corp (South Korea), HORIBA, Ltd. (Japan), Abionic SA (Switzerland), Catalytic Materials (United States), Advanced Nano Products Co. Ltd (South Korea), Chemat Technology Inc. (United States), eSpin Technologies (United States), ELITech Group (France) and GeneFluidics Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Introduction of Artificial Intelligence in Biomedical Nanotechnology " is seen as one of major influencing trends for Biomedical Nanotechnology Market during projected period 2022-2028.
The Biomedical Nanotechnology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Biomedical Nanotechnology Market Report?

Have a Query? Click Here

Other Related Reports

Biofermin Comprehensive Study by Type (Tablets, Powdery, Other), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2026
$ 3500
Gallnuts Acid Comprehensive Study by Type (Industrial Grade, Pharmaceutical Grade, Food Grade), Application (Antioxidants, Biological Activity, Medical applications, Other), Extract (Gallnuts, Sumac,...
$ 3350
Soft Tissue Allograft Comprehensive Study by Type (Cartilage Allografts, Tendon Allografts, Meniscus Allografts, Dental Allografts, Collagen Allografts, Amniotic Allografts), Application (Orthopedic,...
$ 3650
Biological Control Comprehensive Study by Type (Predatory Mites, Insects, Nematodes, Other), Application (Seed Treatment, Post-Harvest, On-Field), Crop (Vegetables, Fruit, Pulses & Oils, Cereals & Gr...
$ 3450
Pet Clones Comprehensive Study by Type (Cloned Cats, Cloned Dogs, Cloned Horse, Others), Application (Public Welfare, Commercial), Methods (Donor Cell Preparation, Oocyte collection and somatic cell ...
$ 3450
Zolpidem Tartrate Comprehensive Study by Type (Zolpidem Tartrate Tablet, Zolpidem Tartrate Injection), Application (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2026
$ 3500